NORVASC 2.5 MG TABLET

amlodipine besylate
$8.7038per EA
High Outlier

Strength

2.5 mg/1

Manufacturer

Pfizer Inc.

NDC

00069152068

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

AMLODIPINE BESYLATE

Approval Type

New Drug (NDA)

FDA Application

NDA019787

On Market Since

7/31/1992

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+4.9%

1Y

+5.7%

3Y

+25.8%

5Y

+25.8%

All

+206.4%